Medical Marijuana, Inc. Subsidiary Phyto Animal Health to Exhibit and Speak at Fetch DVM360 Conference

SAN DIEGO, Dec. 12, 2018 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, subsidiary Phyto Animal Health announced today that it will be sponsoring and exhibiting its line of cannabidiol (CBD) hemp oil animal products at Fetch DVM360, taking place in San Diego from Dec. 13-16. Stephen Cital, Phyto Animal Health Advisory Board Member, will also be at the conference and will be giving three different presentations about cannabis for pets.

“We are proud to be exhibiting and speaking at Fetch DVM360, as the conference aims to educate veterinarians and pet owners on the most recent science behind animal health, including the benefits of hemp CBD in animal treatment,” said Phyto Animal Health CEO Ian Quinn. “Phyto Animal Health is proud to offer our line of premium hemp CBD products to owners aiming to give their pets the highest quality of life.”

Advisory Board Member Cital will be speaking on Dec. 15 about:

  • An Appropriate Approach to Medical Cannabis: 8:00 a.m. — 9:00 a.m.
  • Cannabis: An Innovative Look Into the Future: 9:30 a.m. — 10:30 a.m.
  • Complementing Pharmaceutical Approaches in Pain Management: 11:00 a.m. — 12:00 p.m.

Cital, RVT, SRA, RLAT, VCCS, VTS-Lab Animal is the Executive Director for the Academy of Laboratory Animal Veterinary Technicians and Nurses and also the Training Manager and Surgery Service Lead at Silicon Valley Veterinary Specialists in San Jose, CA. He is also the Co-Founder for the Veterinary Cannabis Academy and committee member for the National Association of Veterinary Technicians in America council of veterinary technician specialties.

Phyto Animal Health offers a line of CBD hemp oil supplements and hemp products targeted to cats, dogs and horses. CBD hemp oil has been researched by top veterinarians for cardiovascular, orthopedic and mental animal health. These products are Triple Lab Tested™ for integrity, safety and consistency and offer an abundant number of terpenes, essential fatty acids and other cannabinoids found naturally in hemp.

“I look forward to representing Phyto Animal Health at Fetch DVM360 and educating fellow veterinarians and pet owners on the benefits of hemp CBD for pets, including how it can be used in pain management,” Cital said. “I believe that with more public education on this topic, access will improve and cannabis research for animal use will become more abundant.”

To learn more about Phyto Animal Health, visit their website at:

To learn more about the Fetch DVM360 conference, visit:

About Phyto Animal Health

As a company that cares about the health and wellbeing of all animals, Phyto Animal Health also cares about the earth. Using the least amount of water and other resources to create its products, the Company aims to leave the smallest footprint possible while helping provide cats, dogs and horses with the nutrients they need to have outstanding mental and physical health.

About Medical Marijuana, Inc.

We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit

To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.


Public Relations Contact:

Andrew Hard

Chief Executive Officer CMW Media

P. 858-264-6600

[email protected]